Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 7080


Immunogenicity and safety of a cell culture-derived inactivated trivalent influenza vaccine (NBP607): A randomized, double-blind, multi-center, phase 3 clinical trial.

Song JY, Cheong HJ, Lee J, Woo HJ, Wie SH, Lee JS, Kim SW, Noh JY, Choi WS, Kim H, Kim KH, Kim WJ.

Vaccine. 2015 Aug 24. pii: S0264-410X(15)01156-1. doi: 10.1016/j.vaccine.2015.08.030. [Epub ahead of print]


A Population-Based, Nationwide Cross-Sectional Study on Influenza Vaccination Status among Cancer Survivors in Korea.

Oh MG, Han MA, Yun NR, Park J, Ryu SY, Kim DM, Choi SW.

Int J Environ Res Public Health. 2015 Aug 21;12(8):10133-49. doi: 10.3390/ijerph120810133.


Incidence of medically attended influenza during pandemic and post-pandemic seasons through the Influenza Incidence Surveillance Project, 2009-13.

Fowlkes A, Steffens A, Temte J, Lonardo SD, McHugh L, Martin K, Rubino H, Feist M, Davis C, Selzer C, Lojo J, Oni O, Kurkjian K, Thomas A, Boulton R, Bryan N, Lynfield R, Biggerstaff M, Finelli L; Influenza Incidence Surveillance Project Working Group.

Lancet Respir Med. 2015 Aug 20. pii: S2213-2600(15)00278-7. doi: 10.1016/S2213-2600(15)00278-7. [Epub ahead of print]


Burden of Illness in UK Subjects with Reported Respiratory Infections Vaccinated or Unvaccinated against Influenza: A Retrospective Observational Study.

Pockett RD, Watkins J, McEwan P, Meier G.

PLoS One. 2015 Aug 19;10(8):e0134928. doi: 10.1371/journal.pone.0134928. eCollection 2015.


BTLA expression declines on B cells of the aged and is associated with low responsiveness to the trivalent influenza vaccine.

Kannan S, Kurupati RK, Doyle SA, Freeman GJ, Schmader KE, Ertl HC.

Oncotarget. 2015 Aug 14;6(23):19445-55.


Immunogenicity and safety of an inactivated quadrivalent influenza vaccine in healthy adults: a phase II, open-label, uncontrolled trial in Japan.

Tsurudome Y, Kimachi K, Okada Y, Matsuura K, Ooyama Y, Ibaragi K, Kino Y, Ueda K.

Microbiol Immunol. 2015 Aug 14. doi: 10.1111/1348-0421.12316. [Epub ahead of print]


Enhanced influenza VLP vaccination with a structurally optimized RIG-I agonist as adjuvant.

Beljanski V, Chiang C, Kirchenbaum GA, Olagnier D, Bloom CE, Wong T, Haddad EK, Trautmann L, Ross TM, Hiscott J.

J Virol. 2015 Aug 12. pii: JVI.01526-15. [Epub ahead of print]


Influenza and pneumococcal vaccination: do older people know if they have been vaccinated?

Laurence A, Lewis P, Gately C, Dixon A.

Aust N Z J Public Health. 2015 Aug 10. doi: 10.1111/1753-6405.12423. [Epub ahead of print]


Retrospective public health impact of a quadrivalent influenza vaccine in the United States.

Crépey P, de Boer PT, Postma MJ, Pitman R.

Influenza Other Respir Viruses. 2015 Aug;9 Suppl 1:39-46. doi: 10.1111/irv.12318.


Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2015-16 Influenza Season.

Grohskopf LA, Sokolow LZ, Olsen SJ, Bresee JS, Broder KR, Karron RA.

MMWR Morb Mortal Wkly Rep. 2015 Aug 7;64(30):818-25.


Sera from middle-aged adults vaccinated annually with seasonal influenza vaccines cross-neutralize some potential pandemic influenza viruses.

Wang W, Facundo EA, Chen Q, Anderson CM, Scott D, Vassell R, Weiss CD.

J Infect Dis. 2015 Aug 4. pii: jiv407. [Epub ahead of print]


Association between Living Arrangements and Influenza Vaccination Rates among Elderly South Korean People: The Fifth Korea National Health and Nutrition Examination Survey (KNHANES V-2).

Cho HM, Kim JY, Hwang SE, Kim JC, Kim MY, Lee SH.

Korean J Fam Med. 2015 Jul;36(4):186-90. doi: 10.4082/kjfm.2015.36.4.186. Epub 2015 Jul 17.


Prevention of serious events in adults 65 years of age or older: A comparison between high-dose and standard-dose inactivated influenza vaccines.

DiazGranados CA, Robertson CA, Talbot HK, Landolfi V, Dunning AJ, Greenberg DP.

Vaccine. 2015 Jul 26. pii: S0264-410X(15)00934-2. doi: 10.1016/j.vaccine.2015.07.006. [Epub ahead of print]


DAMPs and influenza virus infection in ageing.

Samy RP, Lim LH.

Ageing Res Rev. 2015 Jul 19. pii: S1568-1637(15)30007-6. doi: 10.1016/j.arr.2015.07.005. [Epub ahead of print] Review.


Effect of Varying Doses of a Monovalent H7N9 Influenza Vaccine With and Without AS03 and MF59 Adjuvants on Immune Response: A Randomized Clinical Trial.

Jackson LA, Campbell JD, Frey SE, Edwards KM, Keitel WA, Kotloff KL, Berry AA, Graham I, Atmar RL, Creech CB, Thomsen IP, Patel SM, Gutierrez AF, Anderson EL, El Sahly HM, Hill H, Noah DL, Bellamy AR.

JAMA. 2015 Jul 21;314(3):237-46. doi: 10.1001/jama.2015.7916.


Efficacy and immunogenicity of high-dose influenza vaccine in older adults by age, comorbidities, and frailty.

DiazGranados CA, Dunning AJ, Robertson CA, Talbot HK, Landolfi V, Greenberg DP.

Vaccine. 2015 Aug 26;33(36):4565-71. doi: 10.1016/j.vaccine.2015.07.003. Epub 2015 Jul 14.


Hemagglutination Inhibition Antibody Titers as a Correlate of Protection Against Seasonal A/H3N2 Influenza Disease.

Benoit A, Beran J, Devaster JM, Esen M, Launay O, Leroux-Roels G, McElhaney JE, Oostvogels L, van Essen GA, Gaglani M, Jackson LA, Vesikari T, Legrand C, Tibaldi F, Innis BL, Dewé W.

Open Forum Infect Dis. 2015 May 14;2(2):ofv067. doi: 10.1093/ofid/ofv067. eCollection 2015 Apr.


Influenza-attributable burden in United Kingdom primary care.

Fleming DM, Taylor RJ, Haguinet F, Schuck-Paim C, Logie J, Webb DJ, Lustig RL, Matias G.

Epidemiol Infect. 2015 Jul 13:1-11. [Epub ahead of print]


The expression of B & T cell activation markers in children's tonsils following live attenuated influenza vaccine.

Panapasa JA, Cox RJ, Mohn KG, Aqrawi LA, Brokstad KA.

Hum Vaccin Immunother. 2015 Jul 3;11(7):1663-72. doi: 10.1080/21645515.2015.1032486.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk